Search clinical trials for: Poorly controlled glucose

Total 30830 results

Nanjing Jinling Hospital

Unknown

Effectiveness Study of Hydrotherapy Against Pain and Other Symptoms in Diabetes-induced LEAD

Diabetes | Lower Extremity Arterial Disease

China
ActivX Biosciences, Inc.
Kyorin Pharmaceutical Co.,Ltd

Completed

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone

Type 2 Diabetes

United States
Temple University
Nutrisystem, Inc.

Completed

Pilot Study to Assess Pre-packaged, Portion-controlled Meal Plan on Weight Loss (NS)

Type 2 Diabetes

United States
Temple University
University of Pennsylvania; Nutrisystem, Inc.

Completed

The Effects of a Pre-packaged, Portion Controlled Meal Plan on Type 2 Diabetes and Glycemic Control: A Comparison Study

Obesity

United States
Olive View-UCLA Education & Research Institute
Boston Scientific Corporation; Epilepsy Foundation

Completed

External Trigeminal Nerve Stimulation for Epilepsy

Epilepsy | Seizure Disorders

United States
PhaseBio Pharmaceuticals Inc.

Completed

Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States
Odense University Hospital

Completed

The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Denmark
Metabolic Solutions Development Company

Completed

A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator

Type 2 Diabetes Mellitus

United States
National Institute of Diabetes and Digestive and...

Completed

Does Metabolic Syndrome Exist in Anorexia Nervosa?

Anorexia Nervosa | Metabolic Syndrome

United States
University of Malaya

Completed

Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome

Schizophrenia

Malaysia
Freie Universität Berlin
Deutsche Rentenversicherung

Completed

Improvement of a Physically Active Lifestyle (FaBA)

Heart Diseases | Pain | Diabetes Mellitus, Type 2 | Osteoarthritis | Rheumatoid Arthritis | Motivation | Behavior

Germany
Freie Universität Berlin

Completed

Stage-based Exercise Promotion Study (STEPS)

Obesity | Diabetes Mellitus, Type 2

Germany
Freie Universität Berlin

Completed

Online Program Assisting Lifestyle Changes (Asterix 1.0 & Obelix 2.0) (OPAL)

Diabetes Mellitus, Type 2

Germany
Freie Universität Berlin
Boehringer Ingelheim

Completed

Increasing Vitamin Intake and Physical Activity (BIV-BIA)

Heart Diseases | Diabetes Mellitus, Type 2 | Motivation | Behavior

Germany
Sung-Chen Liu
Mackay Memorial Hospital

Completed

Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea (JAS)

Type 2 Diabetes

Taiwan
UConn Health
Actelion

Terminated

Bosentan for Poorly Controlled Asthma

Asthma

United States
University of Minnesota

Withdrawn

Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study

Obesity | Insulin Resistance
Sanofi

Completed

Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs (CHANGING)

Diabetes Mellitus, Type 2

Algeria, Brazil, Israel, Lebanon, Mexico, Morocco, Peru, Saudi Arabia, United Arab Emirates, Venezuela
Sanofi

Completed

Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment (LANCELOT)

Diabetes Mellitus, Type 2

Brazil, Thailand, Slovakia, Poland, Netherlands, Kuwait, Mexico, Korea, Republic of, Czech Republic, Egypt, France, Italy, Romania, Russian Federation, Sweden, Switzerland, United Arab Emirates
University Hospitals, Leicester
Warwick Medical School

Completed

Evaluation of Intermediate Care Clinics for Diabetes (ICCD)

Type 2 Diabetes

United Kingdom
Sheba Medical Center

Unknown

Comparison of Two Insulin Regimens in Optimally-controlled Patients With DM2.

Diabetes Mellitus 2 Type

Israel
University of California, Los Angeles

Completed

Randomized Crossover Study of Magnesium Supplementation

Inflammation | Diabetes Mellitus, Type 2

United States
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Mannkind Corporation

Completed

18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus
Meir Medical Center
Clalit Health Services

Unknown

A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin

Diabetes Type 2

Israel
Hospital Universitario Pedro Ernesto
Novartis

Withdrawn

Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan

Hypertension | Diabetes Mellitus

Brazil
Abbott Products
Quintiles, Inc.

Completed

A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes

Type 2 Diabetes

Bulgaria, Poland, South Africa
Harokopio University

Completed

Effects of Different Coffee Amounts on Energy Intake, Appetite, Glucose Metabolism and Inflammatory Markers

Inflammation | Obesity

Greece
Novartis
Genentech, Inc.

Completed

Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients

Asthma
Nutrisystem, Inc.
University of Pennsylvania

Unknown

Blood Glucose Stability and Variability on Two Diets

Obesity | Type 2 Diabetes

United States
University of Florida

Completed

The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma

Asthma

United States
Public Health Foundation of India
National Heart, Lung, and Blood Institute (NHLBI); All India Institute of Medical... and other collaborators

Unknown

A Multi-site, Individually Randomized, Controlled Translation Trial of Integrated and Comprehensive Care Strategies to Reduce Cardiovascular Disease (CVD) Risk Among 1,120 Type 2 Diabetes Mellitus(T2DM) Patients in South Asia (CARRS)

Hypertension | Type 2 Diabetes Mellitus | Dyslipidaemia

India, Pakistan
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin

Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Adult-Onset
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy

Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Adult-Onset
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet

Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Adult-Onset
Odense University Hospital

Completed

Self-care Behaviour Treatment in Patients With Diabetes - a Randomised Controlled Trial

Diabetes

Denmark
Novartis

Completed

Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy

Diabetes Mellitus, Type 2

Denmark
University Hospital, Clermont-Ferrand

Unknown

Glucose Tolerance in Patients With an Idiopathic Parkinson's Disease

Parkinson's Disease

France
Sanofi

Completed

REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents (REASSURE)

Diabetes Mellitus, Type 2

Australia
CellMed AG, a subsidiary of BTG plc.

Completed

Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Single Doses of CM3.1-AC100 in Patients With Type 2 Diabetes

Type II Diabetes Mellitus

Germany
Kyunghee University Medical Center

Completed

1,5-AG as a Marker of Postprandial Hyperglycemia and Glucose Variability in Well-controlled Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Korea, Republic of
Bristol-Myers Squibb
Merck Sharp & Dohme LLC

Completed

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

Diabetes Mellitus, Type 2

United States, Chile, Hong Kong, Argentina, Austria, Brazil, Canada, Mexico, Peru, Puerto Rico, Philippines, Thailand, Russian Federation, Poland, Germany, Taiwan, Switzerland
InteKrin Therapeutics, Inc.

Completed

A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator

Type 2 Diabetes Mellitus

United States, Mexico
Thomas Jefferson University
National Cancer Institute (NCI)

Terminated

Computer-Assisted Cancer Risk Behavior Counseling

Hypertension | Diabetes Mellitus | Diabetes
Research Unit Of General Practice, Copenhagen

Completed

Randomised Controlled Trial of Structured Personal Care of Type 2 Diabetes Mellitus (DCGP)

Diabetes Mellitus | Health Services Research | Quality of Health Care

Denmark
John Hunter Children's Hospital
Sydney Children's Hospitals Network; Royal Children's Hospital; Royal North Shore... and other collaborators

Unknown

Bolus Insulin Card Calculator Randomised Controlled Study

Type 1 Diabetes

Australia
IRCCS Azienda Ospedaliera Universitaria San Martino...
Santa Chiara Hospital; Istituto Nazionale per lo Studio e la Cura dei Tumori

Unknown

Prospective Controlled Trial on Surgical Treatment of Type 2 Diabetes Patients With BMI 25-30 by Means of Biliopancreatic Diversion (DIA-BPD 25-30)

Type 2 Diabetes Mellitus | Bariatric Surgery | Biliopancreatic Diversion

Italy
University of Pavia

Unknown

Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria

Hypertension | Type 2 Diabetes

Italy

Search clinical trials for: Poorly controlled glucose

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations